Liquid biopsies find distinct genomic profiles in most patients with carcinoma of unknown primary
Bottom Line: Next-generation sequencing of circulating tumor DNA (ctDNA) identified distinct genomic profiles with potentially targetable alterations in 99.7 percent of patients with carcinoma of unknown primary (CUP) who ...
Aug 15, 2017
0
3